Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Age-Related Macular Degeneration and Early Diagnosis of Dementia—Reply

Age-Related Macular Degeneration and Early Diagnosis of Dementia—Reply Letters Conflict of Interest Disclosures: None reported. Corresponding Author: Harmeet S. Gill, MD, FRCSC, Department of Ophthalmology and Vision Sciences, University of Toronto, Mount Sinai 1. Gill HS, Moscato EE, Chang ALS, Soon S, Silkiss RZ. Vismodegib for periocular Hospital, 600 University Ave, Ste 409, Toronto, ON M5G 1X5, Canada and orbital basal cell carcinoma. JAMA Ophthalmol. 2013;131(12):1591-1594. (harmeetgillmd@gmail.com). 2. Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in Conflict of Interest Disclosures: None reported. advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171-2179. 1. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog 3. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012;366 basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. (23):2180-2188. 2013;29(2):87-92. 2. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular 4. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012;366 2013;29(2):87-92. (23):2180-2188. 3. Sekulic A, Migden MR, Oro AE, et al. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Age-Related Macular Degeneration and Early Diagnosis of Dementia—Reply

Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/age-related-macular-degeneration-and-early-diagnosis-of-dementia-reply-Ne0HO6AAtY

References (5)

Publisher
American Medical Association
Copyright
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2014.1797
pmid
25010182
Publisher site
See Article on Publisher Site

Abstract

Letters Conflict of Interest Disclosures: None reported. Corresponding Author: Harmeet S. Gill, MD, FRCSC, Department of Ophthalmology and Vision Sciences, University of Toronto, Mount Sinai 1. Gill HS, Moscato EE, Chang ALS, Soon S, Silkiss RZ. Vismodegib for periocular Hospital, 600 University Ave, Ste 409, Toronto, ON M5G 1X5, Canada and orbital basal cell carcinoma. JAMA Ophthalmol. 2013;131(12):1591-1594. (harmeetgillmd@gmail.com). 2. Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in Conflict of Interest Disclosures: None reported. advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171-2179. 1. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog 3. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012;366 basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. (23):2180-2188. 2013;29(2):87-92. 2. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular 4. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. pathway in patients with the basal-cell nevus syndrome. N Engl J Med. 2012;366 2013;29(2):87-92. (23):2180-2188. 3. Sekulic A, Migden MR, Oro AE, et al.

Journal

JAMA Ophthalmology – American Medical Association

Published: Jul 1, 2014

There are no references for this article.